|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 12, 2018 ) The Asia Pacific Next Generation Antibody Therapeutics market size was around USD 600 million in 2017. It is expected to grow at a CAGR of 14.9% to reach USD 1.2 billion by 2022. It captures 20% of the global market.
Next generation antibody therapeutics have high efficiency and are more safe. Rapid advancements in monoclonal antibodies technology is the reason for this. These advances have improved bifunctional properties, decreased functional size along with immunogenicity. Several medical conditions like cancer; autoimmune diseases etc. are treated using these technologies because of its enhanced properties.
View Full Report: https://www.marketdataforecast.com/market-reports/asia-pacific-next-generation-antibody-therapeutics-market-5417/
Rising number of cases of chronic diseases, rapid advancements in technology, higher investment in R&D and increasing healthcare expenditure are the primary drivers of market growth.
On the other hand, strict administrative guidelines and regulatory requirements and inordinate delays in approval for new drugs along with their high costs are the primary restraints of market growth.
Request for Sample Brochure: https://www.marketdataforecast.com/market-reports/asia-pacific-next-generation-antibody-therapeutics-market-5417/request-sample
The market is segmented by therapeutic application and by technology. Classification by therapeutic application entails Oncology and Autoimmune/Inflammatory Diseases. Classification by technology entails Antibody-Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, and Biosimilar Antibody Products. Biosimilar antibody products in the technology segment accounted for the largest market share thereby dominating the market in the forecast period. Oncology sub-category in the therapeutics application market category captured largest market share and is expected to remain in the lead till 2022.
Inquire before buying: https://www.marketdataforecast.com/market-reports/asia-pacific-next-generation-antibody-therapeutics-market-5417/inquire
Classification by geography entails India, China, Korea, Japan and others. Asia Pacific is likely to be the fastest growing market with the highest CAGR in the forecast period. Economic boom in the emerging economies of India and China are the reasons for this.
Key players in the market include Roche, Seattle Genetics, Takeda, Dyax Corp., and Immunogen. Other players in the market include Amgen, Inc., Biogen, Kyowa Hakko Kirin Co., Ltd., AstraZeneca, Pfizer, Inc., and Xencor, Inc.
Market Segmentation
Technology
Introduction
Antibody-Drug Conjugates (ADCs)
Bispecific Antibodies (BsAbs)
Fc Engineered Antibodies
Antibody Fragments and Antibody-like Proteins
Biosimilar Antibody Products
Therapeutic Application
Introduction
Oncology
Autoimmune/Inflammatory Diseases
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porters Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
